Cite
HARVARD Citation
Viani, R. et al. (2020). Long-Term Safety and Efficacy of Dolutegravir in Treatment-Experienced Adolescents With Human Immunodeficiency Virus Infection: Results of the IMPAACT P1093 Study. Journal of the Pediatric Infectious Diseases Society. pp. 159-165. [Online].